William Brigode1, Caitlin Cohan2, Genna Beattie2, Gregory Victorino2. 1. Department of Surgery, University of California-San Francisco, Oakland California. Electronic address: William.Brigode@alamedahealthsystem.org. 2. Department of Surgery, University of California-San Francisco, Oakland California.
Abstract
BACKGROUND: Alcohol (EtOH) poses a challenge in traumatic brain injuries (TBIs) given its metabolic and neurologic impact. Studies have had opposing results regarding mortality and complication rates in the intoxicated TBI patient. We hypothesized that trauma mechanism, brain injury severity, and blood alcohol concentration (BAC) would influence the impact of EtOH on mortality in TBI. METHODS: We performed a single-institution retrospective review of consecutive adult trauma patients tested for EtOH and a diagnosis of TBI. The primary outcome was mortality, and secondary outcomes included infectious complications. The primary analysis included univariate and multivariate regression comparing mortality between intoxicated and sober patients, at different values of BAC, different brain injury severities, and among mechanisms of trauma. RESULTS: Admission EtOH was assessed in 583 patients with TBI, with 256 testing positive for EtOH and 327 testing negative. Overall, EtOH was associated with lower mortality on univariate analysis (4.7% versus 8.9%, P = 0.05) but not on multivariate analysis (P = 0.21). There was no effect of EtOH on mortality when patients were stratified by brain injury severity or among penetrating trauma victims. However, EtOH was associated with lower overall infectious complications on univariate and multivariate regression. Finally, EtOH was predictive of mortality with an area under the receiver operator characteristic curve of 0.83. CONCLUSIONS: We found that EtOH is not associated with mortality in the patient with TBI, suggesting no causative effect. However, EtOH showed some predictability of mortality based on a receiver operator characteristic analysis. Interestingly, EtOH was associated with lower infectious complications, suggesting an immunomodulatory effect of EtOH in TBI.
BACKGROUND:Alcohol (EtOH) poses a challenge in traumatic brain injuries (TBIs) given its metabolic and neurologic impact. Studies have had opposing results regarding mortality and complication rates in the intoxicated TBIpatient. We hypothesized that trauma mechanism, brain injury severity, and blood alcohol concentration (BAC) would influence the impact of EtOH on mortality in TBI. METHODS: We performed a single-institution retrospective review of consecutive adult traumapatients tested for EtOH and a diagnosis of TBI. The primary outcome was mortality, and secondary outcomes included infectious complications. The primary analysis included univariate and multivariate regression comparing mortality between intoxicated and sober patients, at different values of BAC, different brain injury severities, and among mechanisms of trauma. RESULTS: Admission EtOH was assessed in 583 patients with TBI, with 256 testing positive for EtOH and 327 testing negative. Overall, EtOH was associated with lower mortality on univariate analysis (4.7% versus 8.9%, P = 0.05) but not on multivariate analysis (P = 0.21). There was no effect of EtOH on mortality when patients were stratified by brain injury severity or among penetrating trauma victims. However, EtOH was associated with lower overall infectious complications on univariate and multivariate regression. Finally, EtOH was predictive of mortality with an area under the receiver operator characteristic curve of 0.83. CONCLUSIONS: We found that EtOH is not associated with mortality in the patient with TBI, suggesting no causative effect. However, EtOH showed some predictability of mortality based on a receiver operator characteristic analysis. Interestingly, EtOH was associated with lower infectious complications, suggesting an immunomodulatory effect of EtOH in TBI.
Authors: Josephine Volovetz; Mary Joan Roach; Argyrios Stampas; Gregory Nemunaitis; Michael L Kelly Journal: Top Spinal Cord Inj Rehabil Date: 2021-01-20
Authors: Eric O Yeates; Areg Grigorian; Morgan Schellenberg; Natthida Owattanapanich; Galinos Barmparas; Daniel Margulies; Catherine Juillard; Kent Garber; Henry Cryer; Areti Tillou; Sigrid Burruss; Ryan Arthur Figueras; Georgi Mladenov; Megan Brenner; Christopher Firek; Todd Costantini; Jarrett Santorelli; Terry Curry; Diane Wintz; Walter L Biffl; Kathryn B Schaffer; Thomas K Duncan; Casey Barbaro; Graal Diaz; Arianne Johnson; Justine Chinn; Ariana Naaseh; Amanda Leung; Christina Grabar; Jeffry Nahmias Journal: Eur J Trauma Emerg Surg Date: 2021-05-25 Impact factor: 3.693
Authors: Zhenghui Li; Jin Zhang; Steffen Halbgebauer; Akila Chandrasekar; Rida Rehman; Albert Ludolph; Tobias Boeckers; Markus Huber-Lang; Markus Otto; Francesco Roselli; Florian Olde Heuvel Journal: Burns Trauma Date: 2021-09-30
Authors: Jin Zhang; Zhenghui Li; Akila Chandrasekar; Shun Li; Albert Ludolph; Tobias Maria Boeckers; Markus Huber-Lang; Francesco Roselli; Florian Olde Heuvel Journal: Front Immunol Date: 2022-02-24 Impact factor: 7.561
Authors: Zachary F Stielper; Elizabeth A Fucich; Jason W Middleton; Cecilia J Hillard; Scott Edwards; Patricia E Molina; Nicholas W Gilpin Journal: J Neurotrauma Date: 2020-09-30 Impact factor: 4.869